Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Moroctocog Alfa

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    31/10/2025 Patheon
    U.S.A
    		 Patheon Italia S.p.A. 68225-092 EFMOROCTOCOG ALFA 2014-07-14 2025-12-31 DRUG FOR FURTHER PROCESSING POWDER, FOR SOLUTION (1000[iU]/3mL)
    31/10/2025 Patheon
    U.S.A
    		 Patheon Italia S.p.A. 68225-090 EFMOROCTOCOG ALFA 2014-07-14 2025-12-31 DRUG FOR FURTHER PROCESSING POWDER, FOR SOLUTION (500[iU]/3mL)